Effect of oral clonidine on human cardiovascular responsiveness: a possible explanation of the therapeutic action of the drug in menopausal flushing and migraine
- 31 October 1985
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 92 (11) , 1169-1175
- https://doi.org/10.1111/j.1471-0528.1985.tb03032.x
Abstract
The effect of an alpha-adrenergic agonist, clonidine hydrochloride, on cardiovascular responses to noradrenaline, adrenaline and angiotensin was investigated in menopausal women with hot flushes. The increase in forearm blood flow induced by adrenaline, noradrenaline or angiotensin was significantly less in women treated for at least 6 weeks with clonidine compared with that induced in the women by infusions given before treatment. Pulse rate during the amine infusions was significant lower after clonidine treatment but constrictor responses in the hand were unchanged. These findings cannot be wholly explained in terms of an action of clonidine confined to adrenergic mechanisms and suggest that the drug may influence peripheral vascular responsiveness. Such an effect could explain the mechanism of the beneficial clinical action of the drug in subjects with menopausal flushing or migraine.This publication has 13 references indexed in Scilit:
- Effect of intravenous clonidine on menopausal flushing and luteinizing hormone secretionBJOG: An International Journal of Obstetrics and Gynaecology, 1983
- Effects of Clonidine on Aortic Pressure-Diameter and Elastic Stiffness-Stress Relations in Anaesthetized RabbitsClinical Science, 1981
- CARDIOVASCULAR RESPONSES DURING THE MENOPAUSAL HOT FLUSHBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- IMPAIRED CARDIOVASCULAR RESPONSIVENESS IN LIVER DISEASEThe Lancet, 1975
- Menopausal Flushing: Double-blind Trial of a Non-hormonal MedicationBMJ, 1974
- Marihuana SmokingNew England Journal of Medicine, 1972
- EVALUATION OF CLONIDINE IN PROPHYLAXIS OF MIGRAINE: Double-blind Trial and Follow-upThe Lancet, 1972
- A POSSIBLE PHARMACOLOGICAL APPROACH TO MIGRAINEThe Lancet, 1969
- Localization of the hypotensive effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, catapresan)European Journal of Pharmacology, 1969
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155)European Journal of Pharmacology, 1968